The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TACE 2: A randomized placebo-controlled, double-blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC)—Background.
 
Tim Meyer
Consulting or Advisory Role - Boehringer Ingelheim; Novartis
Research Funding - Bayer (Inst); BTG (Inst); Ipsen (Inst)
 
Richard Fox
No Relationships to Disclose
 
Yuk Ting Ma
No Relationships to Disclose
 
Paul J. Ross
Honoraria - Bayer; Celgene; Merck Serono; Roche; Sanofi; Sirtex Medical
Consulting or Advisory Role - Bayer; Celgene; Merck Serono; Roche; Sanofi; Sirtex Medical
Research Funding - Sanofi
Travel, Accommodations, Expenses - Amgen; Bayer; Celgene; Merck Serono
 
Martin James
Consulting or Advisory Role - Cook Medical
 
Richard Strugess
Honoraria - Boston Scientific
Consulting or Advisory Role - Boston Scientific
 
Clive Stubbs
No Relationships to Disclose
 
Lucy Wall
No Relationships to Disclose
 
Anthony Watkinson
Consulting or Advisory Role - BTG
Travel, Accommodations, Expenses - TERUMO
 
Nigel Hacking
Consulting or Advisory Role - BTG
Research Funding - Cook Medical (Inst)
Travel, Accommodations, Expenses - Boston Scientific
 
T.R. Jeffry Evans
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Baxter; Bristol-Myers Squibb; Eisai; Karus Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Celgene
Research Funding - AstraZeneca (Inst); Basilea (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); e-Therapeutics (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Merck (Inst); Roche/Genentech (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Peter Collins
Honoraria - Intercept Pharmaceuticals
Consulting or Advisory Role - Intercept Pharmaceuticals
Travel, Accommodations, Expenses - Bayer
 
Richard Hubner
Consulting or Advisory Role - BTG; Celgene
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Sanofi (Inst)
 
John Neil Primrose
No Relationships to Disclose
 
Philip James Johnson
Honoraria - Wako Life Science
Consulting or Advisory Role - MSD
Speakers' Bureau - Wako Life Science
Research Funding - Wako Life Science
Travel, Accommodations, Expenses - Wako Life Science
 
Daniel H. Palmer
No Relationships to Disclose